• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 28-April 1, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

March 28-April  1, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/31/11Washington, DCMolly MuldoonN/AOpening Remarks at the Export-Import Bank’s 2011 Annual Conference
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs3/28/11-4/1/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs3/28/11-4/1/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration3/28/11-4/1/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/28/11-4/1/11 N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget3/28/11-4/1/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine4/1/11Rockville, MDSteve Vaughn, Larisa Rudenko, Dave WhiteLarry Stobbs (Stobbs Consulting, Inc.); Terry Clark (Agri-Food Solutions, Inc.)Innovation in Animal Health
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/29/11Washington, DCSeveral FDA Officials and Staff MembersSeveral Representatives from Private Industry, Government, and AcademiaIOM Workshop on Medical Countermeasures Initiative Regulatory Science
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/30/11N/AN/ASeveral Representatives from Pharmaceutical, Private Industry, Government, and AcademiaR&D Working Group:  Decades of Vaccines Collaboration
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/1/11Silver Spring, MDSeveral FDA OfficialsDiane Dorman  (NORD); Wayne Pines (APCO Worldwide); Richard Kline (CDC)FDA's Regulatory Science Initiative
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition3/28/11- 4/1/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs3/28/11-4/1/11 N/AN/AN/ANo Significant Meetings
Beth Martino, Associate Commissioner for External Affairs3/28/11-4/1/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research3/30/11Bethesda, MDJay Epstein and other FDA Staff MembersSeveral Representatives from AABBOpening Remarks at AABB Liaison Meeting
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health3/30/11Silver Spring, MDSeveral FDA Officials and Staff MembersMichael Mussallem (Edwards Lifesciences)Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research4/1/11-4/2/11College Station, TXN/AN/A8th Annual Conference of the MidSouth Computational Biology and Bioinformatics Society (MCBIOS 2011)
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/28/11-4/1/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel3/28/11Silver Spring, MDDavid Mednick, John VerbetenNeal Beaton, Michael Gaba, Vanessa Sciarra (Holland & Knight); Tom Hirshfield (JTI International)Duty-Free Imports
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs3/28/11-4/1/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/28/11-4/1/11N/AN/AN/ANo Significant Meetings